Deerfield Management Company, L.P. (Series C) Applied Therapeutics Inc. Transaction History

Deerfield Management Company, L.P. (Series C)

$4.04 Billion
Q4 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2020 Nov 16, 2020	SELL	$19.43 - $35.36 $5.41 Million - $9.84 Million	-278,359 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$19.54 - $55.47 $5.44 Million - $15.4 Million	278,359 New	278,359 $9.1 Million

Others Institutions Holding APLT

# of Institutions

129

Shares Held

111M

Call Options Held

1.1M

Put Options Held

800K

Vestal Point Capital, LP New York, NY

11.5M
Shares

$5.98 Million
0.58% of portfolio
Vr Adviser, LLC New York, NY

9.99M
Shares

$5.2 Million
1.4% of portfolio
Propel Bio Management, LLC Los Angeles, CA

9.62M
Shares

$5 Million
8.18% of portfolio
Morgan Stanley New York, NY

8.82M
Shares

$4.58 Million
0.0% of portfolio
Schonfeld Strategic Advisors LLC New York, NY

8.76M
Shares

$4.56 Million
0.05% of portfolio

View Full List

About Applied Therapeutics Inc.

Ticker APLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,700
Market Cap $25M
Description
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...

More about APLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account